-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Context Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.25M, a 55% increase year-over-year.
- Context Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$18.6M, a 0.88% increase year-over-year.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24M, a 61.5% decline from 2022.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.8M, a 41.9% decline from 2021.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$10.5M, a 257% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)